Examples of 'aprotinin' in a sentence
Meaning of "aprotinin"
aprotinin (noun): A drug that is used to reduce bleeding during complex surgery or medical procedures. It works by slowing down the breakdown of blood clots
Show more definitions
- A polypeptide, obtained from bovine lung tissue, that acts as a protease inhibitor, and is used in surgery to reduce bleeding
How to use "aprotinin" in a sentence
Basic
Advanced
aprotinin
It is unknown whether aprotinin is excreted in human milk.
Aprotinin is especially effective for inhibiting urokinase.
It was equipotent with aprotinin at inhibiting human plasmin.
She would add heparin and aprotinin.
All risks of aprotinin known to date were considered.
Questions and answers on the suspension of aprotinin.
With native aprotinin a moderate inhibition was observed.
This document presents the conclusions on aprotinin.
Use of aprotinin polypeptides as carriers in pharmaceutical conjugates.
The kinetic profile of cytokines was not affected by aprotinin.
Aprotinin is the antifibrinolytic drug studied the most.
Data for recombinant aprotinin are shown for comparison.
Aprotinin should be infused using a central venous catheter.
The excretion of aprotinin in urine was negligible.
Aprotinin can only be provided from a bovine source.
See also
Data is shown using either recombinant bikunin or aprotinin.
Aprotinin is a quite common protease inhibitor.
One such protease inhibitor is aprotinin.
Bovine aprotinin is absent from the cryoprecipitate composition.
A suitable kallikrein inhibitor for use herein is aprotinin.
A sample in which aprotinin was introduced initially served as a control.
These molecules can conceivably be attached to aprotinin vÃa a linker.
Aprotinin is eliminated by the kidneys.
The context is a fibrin matrix with aprotinin as an example.
Aprotinin linked to excess deaths after coronary artery surgery.
Dimeric and trimeric aprotinin.
Aprotinin is a broad spectrum protease inhibitor which has antifibrinolytic properties.
A suitable kallikrein inhibitor for use in the present invention is aprotinin.
Aprotinin was administered through the central venous access without hemodynamic repercussions.
The premix may optionally contain aprotinin to reduce the rate of decomposition.
Animal studies did not provide any evidence of teratogenic or other embryotoxic effects of aprotinin.
The addition of aprotinin to the incubation medium prevented this cell dissociation.
This necessitates the use of agents such as aprotinin in the growth media.
The high cost of aprotinin is one of the problems that hinder its use.
Also the coagulation tests revealed no differences related to the presence or absence of aprotinin.
The effectiveness of the preventive regimen with aprotinin has been thoroughly demonstrated in literature.
With respect to the other response variables the analogues equaled or were superior to aprotinin.
The amended prescribing information on aprotinin medicines for doctors can be found here.
It is preferable that the dermal preparation of the present invention contain aprotinin as well.
The trial assessing the effect of aprotinin was too small to provide reliable data.
Homoplasmic tobacco lines expressing are used to determine the expression of the aprotinin protein.
Tranexamic acid and bovine aprotinin may be excluded from the cryoprecipitate composition.
The petA sequence is included to direct the expressed aprotinin protein to the thylakoid.
A particular feature of this protease is that the amidolytic activity is efficiently inhibited by aprotinin.
A yeast clone expressing natural aprotinin served as a positive control and is shown for comparison.
This invention relates to a measurement of natriuretic peptide in specimens which do not contain aprotinin.
In this case tranexamic acid and bovine aprotinin are absent from the cryoprecipitate concentrate.
The ratio obtained for this conjugation was three biotin for each aprotinin.
Administration of aprotinin in high doses significantly reduces blood loss in connection with cardiac surgery.
The results also showed that textilinin bound less tightly to plasmin than did aprotinin.
